Chinese biotech firm Immorna raises $100m in extended Series A rounds
Previous backers also re-upped in the round.
Stay updated with breaking news from Structural Reform Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Previous backers also re-upped in the round.
The company offered a combined 19.68% of its shares to the consortium
Transcenta Holding Limited, a global biotherapeutics company with integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, completed a 105m USD crossover financing. China Structural Reform Fund led the financing round, participated by new investors including Country Garden Venture Capital, Qatar Investment Authority, and other prominent institutional investors. Existing investors including CCT China Merchants Fund, Lilly Asia Ventures, Teng Yue Partners, Sequoia Capital China and others also participated in this round. The proceeds from new fund...
Transcenta Closes $105 Million in Crossover Financing Published : Wednesday, December 23, 2020, 8:00 am ACROFAN=PRNewswire | mediainquiries@prnewswire.com | SNS HONG KONG and SUZHOU, China, and HANGZHOU, China, Dec. 23, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the completion of a 105 million USD crossover financing. China Structural Reform Fund led the financing round, participated by new investors incl...